Exploratory analysis of target concentration of lenvatinib in the treatment of hepatocellular carcinoma

ConclusionsConsidering these results, we propose that the target trough concentration of lenvatinib could be 36.8 –71.4 ng/mL for maintaining disease control status and reducing grade ≥ 3 toxicity in the treatment of HCC.
Source: Cancer Chemotherapy and Pharmacology - Category: Cancer & Oncology Source Type: research